| Clinical Sciences Director, Clinical Pharmacology |
East Hanover |
Etats-Unis |
Biomedical Research |
Pharma Research |
Recherche & Développement |
nov 15, 2024 |
| Clinical Research Associate/ Senior Clinical Research Associate |
Guangzhou (Guangdong Province) |
Chine |
Development |
Innovative Medicines |
Recherche & Développement |
nov 14, 2024 |
| Study Leader |
East Hanover |
Etats-Unis |
Development |
Innovative Medicines |
Recherche & Développement |
nov 14, 2024 |
| CRA (Remote) |
Field Non-Sales (USA) |
Etats-Unis |
Development |
Innovative Medicines |
Recherche & Développement |
nov 14, 2024 |
| US Lead, AI for Discovery Chemistry (AI4D) |
Cambridge (USA) |
Etats-Unis |
Biomedical Research |
Pharma Research |
Recherche & Développement |
nov 14, 2024 |
| Research Scientist |
Cambridge (USA) |
Etats-Unis |
Biomedical Research |
Pharma Research |
Recherche & Développement |
nov 14, 2024 |
| Research Scientist / Senior Scientist (Dual Posting) |
Cambridge (USA) |
Etats-Unis |
Biomedical Research |
Pharma Research |
Recherche & Développement |
nov 14, 2024 |
| Medical Science Liaison-Oncology-Breast Cancer |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Recherche & Développement |
nov 14, 2024 |
| Medical Head, Neuroscience |
New South Wales (NSW) |
Australie |
International |
Innovative Medicines |
Recherche & Développement |
nov 14, 2024 |
| RA RegCMC Manager |
Hyderabad (Office) |
Inde |
Development |
Innovative Medicines |
Recherche & Développement |
nov 14, 2024 |
| SSO Study Start-up Manager |
Munich (Non-Sales Force) (Novartis Pharma GmbH) |
Allemagne |
Development |
Innovative Medicines |
Recherche & Développement |
nov 14, 2024 |
| CSR Appendices Oversight Manager |
London (The Westworks) |
Royaume-Uni de Grande-Bretagne et d'Irl. du Nord |
Development |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| SSO Study Start Up Country Head |
London (The Westworks) |
Royaume-Uni de Grande-Bretagne et d'Irl. du Nord |
Development |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| Study & Site Operations Country Manager - Saudi Arabia |
Riyadh |
Royaume d'Arabie Saoudite |
Development |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| Associate Expert Science & Technology (m/f/d) |
Basel (City) |
Suisse |
Development |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| Study Start Up Senior Lead (Associate Director) |
Dublin (NOCC) |
Irlande |
Development |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| Global Regulatory Publishing Associate |
Dublin (NOCC) |
Irlande |
Development |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| Medical Governance Lead |
London (The Westworks) |
Royaume-Uni de Grande-Bretagne et d'Irl. du Nord |
International |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| Medical Science Liaison (MSL) Cardiovascular Metabolic lower Manhattan, Staten Island and Brooklyn Remote |
Field Non-Sales (USA) |
Etats-Unis |
US |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| Pharmacien Enregistrement (h/f) |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Development |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| Senior Expert Science & Technology, Process Development |
Durham |
Etats-Unis |
Development |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| External Operations Manager |
Hyderabad (Office) |
Inde |
Development |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| Research Scientist II |
San Diego |
Etats-Unis |
Biomedical Research |
Pharma Research |
Recherche & Développement |
nov 13, 2024 |
| Senior Expert Science & Technology - I |
Changshu (Jiangsu Province) |
Chine |
Development |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| Medical Partner, RLT |
Taipei |
Taiwan |
International |
Innovative Medicines |
Recherche & Développement |
nov 13, 2024 |
| Customer Engagement Associate |
Santiago |
Chili |
International |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Senior Regulatory Affairs Manager |
Vietnam |
République socialiste du Viêt Nam |
Development |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Feasibility Manager (m/w/d) |
Bavaria (without Assumption Day) (Novartis Pharma GmbH) |
Allemagne |
Development |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Medical Science Liaison Manager, RLT Radioligandentherapie (m/w/d). Gebiet: Nordrhein |
North Rhine-Westphalia (Novartis Pharma GmbH) |
Allemagne |
International |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Head of Clinical Manufacturing, TRD (f/m/d) / Vodja klinične proizvodnje TRD (ž/m/d) |
Mengeš |
République de Slovénie |
Development |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Global Program Regulatory Manager |
London (The Westworks) |
Royaume-Uni de Grande-Bretagne et d'Irl. du Nord |
Development |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Znanstveni Svetovalec Ekspert / Associate Director Science & Technology |
Mengeš |
République de Slovénie |
Development |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Vodja oddelka Analitskih operacij / Senior Manager Analytical Operations |
Mengeš |
République de Slovénie |
Development |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Principal Scientist I |
Hyderabad (Office) |
Inde |
Biomedical Research |
Pharma Research |
Recherche & Développement |
nov 12, 2024 |
| Global Regulatory Submission Publishing Associate |
Hyderabad (Office) |
Inde |
Development |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Director Process Analytical Sciences |
Schaftenau |
Autriche |
Development |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Medical Field Trainer |
Head Office (Japan) (Pharmaceuticals) |
Japon |
International |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Associate Clinical Sciences Trial Leader |
Shanghai (Shanghai) |
Chine |
Biomedical Research |
Pharma Research |
Recherche & Développement |
nov 12, 2024 |
| (Senior) Group PV Head- Safety Physician/PV Physician |
Beijing (Beijing) |
Chine |
Development |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| MSL Manager, BC |
Shanghai (Shanghai) |
Chine |
International |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Medical Advisor, BC |
Shanghai (Shanghai) |
Chine |
International |
Innovative Medicines |
Recherche & Développement |
nov 12, 2024 |
| Medical Science Liaison |
Shenyang (Liaoning Province) |
Chine |
International |
Corporate |
Recherche & Développement |
nov 12, 2024 |
| Scientific Education Manager (m/w/d) |
Munich (Non-Sales Force) (Novartis Pharma GmbH) |
Allemagne |
International |
Innovative Medicines |
Recherche & Développement |
nov 11, 2024 |
| Associate Director Science & Technology. PDU Speciality PHAD IN |
Hyderabad (Office) |
Inde |
Development |
Innovative Medicines |
Recherche & Développement |
nov 11, 2024 |
| Manager, External Service Provider Engagement. |
Hyderabad (Office) |
Inde |
Development |
Innovative Medicines |
Recherche & Développement |
nov 11, 2024 |
| Senior Scientist - Cell Pharmacology CVM |
Cambridge (USA) |
Etats-Unis |
Biomedical Research |
Pharma Research |
Recherche & Développement |
nov 11, 2024 |
| Global Learning Partner, Associate Director |
Cambridge (USA) |
Etats-Unis |
Biomedical Research |
Pharma Research |
Recherche & Développement |
nov 11, 2024 |
| Associate Director Science and Technology (Oral Solid) |
Hyderabad (Office) |
Inde |
Development |
Innovative Medicines |
Recherche & Développement |
nov 11, 2024 |
| Mass Spectrometry Expert Science & Technology (m/f/d) |
Schaftenau |
Autriche |
Development |
Innovative Medicines |
Recherche & Développement |
nov 08, 2024 |
| Scientific Excipient Expert – Oral and Innovative Dosage Forms (80-100%) |
Basel (City) |
Suisse |
Development |
Innovative Medicines |
Recherche & Développement |
nov 08, 2024 |